Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Premature hair graying: a multifaceted phenomenon.
Desai DD, Karim M, Nohria A, Needle C, Brinks A, Kearney CA, Ridge A, Mesinkovska N, Shapiro J, Lo Sicco KI. Desai DD, et al. Among authors: mesinkovska n. Int J Dermatol. 2024 Dec 19. doi: 10.1111/ijd.17580. Online ahead of print. Int J Dermatol. 2024. PMID: 39697103 Review.
Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement.
Akiska YM, Mirmirani P, Roseborough I, Mathes E, Bhutani T, Ambrosy A, Aguh C, Bergfeld W, Callender VD, Castelo-Soccio L, Cotsarelis G, Craiglow BG, Desai NS, Doche I, Duque-Estrada B, Elston DM, Goh C, Goldberg LJ, Grimalt R, Jabbari A, Jolliffe V, King BA, LaSenna C, Lenzy Y, Lester JC, Lortkipanidze N, Lo Sicco KI, McMichael A, Meah N, Mesinkovska N, Miteva M, Mostaghimi A, Ovcharenko Y, Piliang M, Piraccini BM, Rakowska A, Salkey KS, Schmidt A, Shapiro J, Sibbald C, Sinclair R, Suchonwanit P, Taylor S, Tosti A, Vañó-Galván S, Wall DR, Fu JM. Akiska YM, et al. Among authors: mesinkovska n. JAMA Dermatol. 2025 Jan 1;161(1):87-95. doi: 10.1001/jamadermatol.2024.4593. JAMA Dermatol. 2025. PMID: 39565602
Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial.
Sinclair R, Mesinkovska N, Mitra D, Wajsbrot D, Law EH, Wolk R, King B. Sinclair R, et al. Among authors: mesinkovska n. Am J Clin Dermatol. 2025 Jan;26(1):109-119. doi: 10.1007/s40257-024-00899-4. Epub 2024 Oct 23. Am J Clin Dermatol. 2025. PMID: 39441519 Free PMC article. Clinical Trial.
Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis.
Mesinkovska N, King B, Zhang X, Guttman-Yassky E, Magnolo N, Sinclair R, Mizuashi M, Shapiro J, Peeva E, Banerjee A, Takiya L, Cox LA, Wajsbrot D, Kerkmann U, Law E, Wolk R, Schaefer G. Mesinkovska N, et al. J Dermatol. 2024 Nov;51(11):1414-1424. doi: 10.1111/1346-8138.17442. Epub 2024 Sep 27. J Dermatol. 2024. PMID: 39328096 Clinical Trial.
171 results